Skip to main content
. 2024 Apr 2;14:7746. doi: 10.1038/s41598-023-49932-2

Table 2.

ADMET profiling of compound S1.

Compound ADMET analysis
P-gp Cyp450 substrate CYP450 Inhibitor
BBB HIA Solubility Substrate Inhibition ROCT 2C9 2D6 3A4 1A2 2C9 2D6 2C19 3A4 CYP IP AMES Carcinogens
S1  +  − 3.25  +   +  Low

BBB blood–brain barrier; HIA human intestinal absorption; CYP450 cytochrome P450; CYP IP CYP inhibitory promiscuity; ROCT renal organic cation transportation; + present; − not present.